AI summary · may contain errors
In elective total hip or knee arthroplasty, aspirin (81 mg twice daily) was not noninferior to rivaroxaban or warfarin for death or symptomatic VTE at 6 months.
- 1 cited this week
- 1 on Bluesky
Moving in New England Journal of Medicine.
Rebuilt
AI summary · may contain errors
In elective total hip or knee arthroplasty, aspirin (81 mg twice daily) was not noninferior to rivaroxaban or warfarin for death or symptomatic VTE at 6 months.
Newest first · last 60 days
AI summary · may contain errors
In a single-center Zurich cohort of 219 adults with confirmed cerebral venous thrombosis, adjusting for age and body-mass index removed women’s excess headache and cortical vein involvement.
AI summary · may contain errors
Aspirin alone after total hip or knee arthroplasty is noninferior to rivaroxaban followed by aspirin for symptomatic venous thromboembolism, with rates of 0.48% vs 0.45%.
AI summary · may contain errors
A single infusion of amrecibart or cenvacibart reduced adjudicated venous thromboembolism by day 14 after PICC placement, with 20% vs 43% on placebo.
AI summary · may contain errors
In 48 patients with acute pulmonary embolism, platelet lipidome remodeling is linked to shifts in platelet subfractions, with RV distress showing higher aggregatory and lower procoagulant platelets.
AI summary · may contain errors
In 5213 patients with acute pulmonary embolism, major bleeding occurred in 3.1% within 30 days, with 78 early (<7 days) and 81 late (≥7 days) events.
AI summary · may contain errors
A 54-year-old woman with subacute exertional dyspnea after heavy lifting and chronic upper-limb strain presents an axillary mass in the context of pulmonary embolism.
AI summary · may contain errors
Higher measured lipoprotein(a) levels are associated with incident venous thromboembolism in this cohort study, quantifying risk across participants.
AI summary · may contain errors
In 712 CTEPH patients, prior VTE history (n=576, 80.9%) defines a distinct thrombotic phenotype with more proximal disease (92.5% vs 66.2%) and higher endarterectomy use (22.6% vs 3.7%).
Journals this month
Topics moving, week to 17 Nov 2026
By field